By Matthew Brady 
Nanyang Technological University, Singapore and the National Healthcare Group have launched a new Centre of AI in Medicine (C-AIM) in Singapore, aiming to revolutionise patient care and inform public health policies through research activities.
The studies will offer critical insights into how AI can be effectively integrated into clinical workflows, with a focus on addressing the specific needs of local healthcare systems.
C-AIM will prioritise areas such as mental health, elderly care, medical imaging, and cancer screening, aligning with Singapore’s National AI Strategy to promote the adoption of AI-driven healthcare solutions.
The centre brings together over 100 researchers, clinicians, and industry partners, including international collaborators such as the Yale School of Medicine and Olympus Singapore. This multidisciplinary team will explore AI applications across fields like medicine, computer engineering, data analytics, social science, ethics, and implementation science. Their collective expertise will help translate AI innovations into clinical practice, ensuring they are both relevant and beneficial to patients and the broader population.
Key challenges the centre aims to address include the need for clinical evidence demonstrating AI’s impact on patient outcomes, the ethical and legal implications of AI, and evidence that AI can reduce healthcare costs and manpower requirements.
C-AIM will also conduct AI simulation and implementation studies, allowing healthcare professionals to rigorously test AI tools before deployment in real-world settings.
Equipped with cutting-edge GPU infrastructure, the centre will accelerate AI and machine learning research while maintaining dedicated research facilities to ensure data privacy.
